Sarcoma  >>  ombrabulin (AVE8062)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ombrabulin (AVE8062) / Sanofi
NCT00699517 / 2007-003592-39: A Study of AVE8062 in Advanced-stage Soft Tissue Sarcoma After Failure of Anthracycline and Ifosfamide Chemotherapies

Completed
3
355
US, Europe, RoW
OMBRABULIN (AVE8062), Placebo
Sanofi
Sarcoma
04/13
04/13

Download Options